A nutritional composition comprising at least an effective amount of geranylgeranylacetone or derivative of geranygeranylacetone and an effective amount of glutamine or derivative of glutamine, wherein the ingredients act substantially simultaneously to increase protein synthesis and inhibit protein degradation in skeletal muscle, via enhanced expression of heat shock proteins in cells, particularly heat shock protein 72. A method of same is also provided.
An effervescent dietary composition for enhancing the delivery of a dietary ingredient to a human comprises dissolving an effervescent containing one or more dietary ingredients and two ingredients capable of reacting to produce effervescence in water. Once the mixture has completely dissolved the solution is immediately ingested, and an effective amount of a dietary ingredient is absorbed. Preferably, the effervescent is in the form of a tablet which contains one or more dietary ingredients, such as Cissus quadrangularis extract, hydroxycitric acid, corosolic acid, caffeine anhydrous and green tea extract, and a mixture of acids, and basic salts.
The present invention relates to a method of improving the energy status of an individual by enhancing the usage of lactate. Improved lactate usage is accomplished through a composition comprising lactate precursors, adrenergic receptor agonists and insulinotropic agents.
A nutritional composition comprising at least L-carnitine fumarate, red wine extract, and saw palmetto extract is provided to maintain skeletal muscle androgen receptivity, via simultaneous increase in the availability of androgen receptors and improved availability of testosterone, while at the same time reducing some of the adverse effects of increased testosterone levels. A method of same is also provided. The present invention further comprises one or more of N-acetyl L-Carnitine, Ubidecarenone (coenzyme Q10), Idebenone, Decylubiquinone, Astaxanthin, and Ginsenoside Rb1.
The present invention describes compounds produced from an ammo acid molecule and a fatty acid molecule The compounds being in the form of ammo acid-fatty acid compounds of Formula I being bound by an anhydride linkage, or mixtures thereof made by reacting ammo acids or derivatives with an appropriate fatty acid previously reacted with a thionyl halide. Wherein R1 is selected from alkanes or alkenes and R2 is selected from hydrogen, methyl, isopropyl, isobutyl, sec butyl, acetylamide, propylamide, butyl- 1 -amine and 1 -propyl guamdme The administration of such molecules provides supplemental ammo acids with enhanced bioavailability and the additional benfits conferred by the specific fatty acid
C07C 279/14 - Dérivés de la guanidine, c.-à-d. composés contenant le groupe les atomes d'azote liés par des liaisons simples ne faisant pas partie de groupes nitro ou nitroso ayant des atomes d'azote de groupes guanidine liés à des atomes de carbone acycliques d'un squelette carboné étant substitué de plus par des groupes carboxyle
The present invention describes compounds produced from a creatine molecule and a fatty acid molecule. The compounds being in the form of creatine-fatty acid compounds being bound by an anhydride linkage, or mixtures thereof made by reacting creatine or derivatives thereof with an appropriate fatty acid previously reacted with a thionyl halide. The administration of such molecules provides supplemental creatine with enhanced bioavailability and the additional benefits conferred by the specific fatty acid. Formula (I).
C07C 279/14 - Dérivés de la guanidine, c.-à-d. composés contenant le groupe les atomes d'azote liés par des liaisons simples ne faisant pas partie de groupes nitro ou nitroso ayant des atomes d'azote de groupes guanidine liés à des atomes de carbone acycliques d'un squelette carboné étant substitué de plus par des groupes carboxyle
The present invention describes compounds produced from a creatine molecule and a fatty acid molecule. The compounds being in the form of creatine-fatty compounds bound by an amide linkage, or mixtures thereof produced by reacting creatine or derivatives thereof with an appropriate fatty acid in the presence of dichloromethane and a pyridine catalyst, previously reacted with a thionyl halide. The administration of such molecules provides supplemental creatine with enhanced bioavailability and the additional benefits conferred by the specific fatty acid. Formula (I)
The present invention describes compounds produced from an amino acid molecule and a fatty acid molecule. The compounds being in the form of amino-fatty acid compounds being bound by an amide linkage, or mixtures thereof made by reacting amino acids or derivatives thereof with an appropriate fatty acid previously reacted with a thionyl halide. The administration of such molecules provides supplemental amino acids with enhanced bioavailability and the additional benefits conferred by the specific fatty acid.
C07C 233/47 - Amides d'acides carboxyliques ayant des atomes de carbone de groupes carboxamide liés à des atomes d'hydrogène ou à des atomes de carbone acycliques ayant l'atome d'azote d'au moins un des groupes carboxamide lié à un atome de carbone d'un radical hydrocarboné substitué par des groupes carboxyle avec le radical hydrocarboné substitué lié à l'atome d'azote du groupe carboxamide par un atome de carbone acyclique ayant l'atome de carbone du groupe carboxamide lié à un atome d'hydrogène ou à un atome de carbone d'un squelette carboné acyclique saturé
C07C 233/49 - Amides d'acides carboxyliques ayant des atomes de carbone de groupes carboxamide liés à des atomes d'hydrogène ou à des atomes de carbone acycliques ayant l'atome d'azote d'au moins un des groupes carboxamide lié à un atome de carbone d'un radical hydrocarboné substitué par des groupes carboxyle avec le radical hydrocarboné substitué lié à l'atome d'azote du groupe carboxamide par un atome de carbone acyclique ayant l'atome de carbone du groupe carboxamide lié à un atome de carbone d'un squelette carboné acyclique non saturé
A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
The present invention relates to a method administering to a mammal between from about 0.01 mg and about 4.9 mg of melatonin followed by physical exercise wherein said exercise occurs within 60 minutes following said administration of melatonin to increase serum growth hormone levels.
A dietary supplement and method for supporting weight loss and reducing the waist circumference of an individual, the dietary supplement comprisingτ an extract of Cissus Quadrangularis stem and leaf, an extract of Green Tea leaf and an effective amount of Caffeine Anhydrous. The dietary supplement may further comprise at least one of Chromium Polynicotinate, an extract of Soy Bean Albumin, Pyridoxine Hydrochloride, L-selenomethionine, Cyanocobalmin, Yohimbine Hydrochloride and Folic Acid.
The present invention relates to a method for increasing the rate of bioavailability of orally administered supplemental dietary ingredients through the process of fine-milling to increase the rate of dissolution of the ingredients. The ingredients to be fine-milled are ingredients suitable for use in supplemental dietary compositions.
A23K 1/16 - additionnés d'éléments nutritifs accessoires; Blocs de sel
A23L 1/00 - Aliments ou produits alimentaires; Leur préparation ou traitement (leur conservation en général A23L 3/00)
A23L 1/025 - Traitement physique, p.ex. par énergie ondulatoire, par irradiation, par des moyens électriques, par des champs magnétiques (cuisson A23L 1/01; conservation A23L 3/00, A23B)
A23P 1/00 - Mise en forme ou traitement des produits alimentaires
A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
12.
METHOD FOR A SUPPLEMENTAL DIETARY COMPOSITION HAVING A MULTI-PHASE DISSOLUTION PROFILE
The present invention relates to a method and composition for achieving a multi-phasic dissolution prolife through the process of fine-milling to increase the rate of dissolution of ingredients. The ingredients to be fine-milled are ingredients suitable for use in supplemental dietary compositions.
A23K 1/16 - additionnés d'éléments nutritifs accessoires; Blocs de sel
A23L 1/025 - Traitement physique, p.ex. par énergie ondulatoire, par irradiation, par des moyens électriques, par des champs magnétiques (cuisson A23L 1/01; conservation A23L 3/00, A23B)
A23P 1/00 - Mise en forme ou traitement des produits alimentaires
A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
13.
METHOD FOR IMPROVING THE ORAL ADMINISTRATION OF ALPHA-LIPOIC ACID
The invention provides a method for reducing esophageal irritation associated with alpha-lipoic acid upon oral administration through the use of the trometamol salt of alpha-lipoic acid. The present invention also provides for the increased solubility of alpha-lipoic acid through the use of the trometamol salt of alpha-lipoic acid. The trometamol salt of alpha-lipoic acid, as provided by the present invention can be used as a substitute for regular, non-salt forms alpha-lipoic acid in dietary supplement compositions.
C07D 341/00 - Composés hétérocycliques contenant des cycles comportant au moins trois atomes de soufre comme uniques hétéro-atomes du cycle
C07D 409/00 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre comme uniques hétéro-atomes du cycle
14.
THE USE OF COMPOSITIONS COMPRISING KETOACIDS AND AMINO ACIDS FOR INCREASING MUSCLE MASS AND MUSCLE PERFORMANCE
Compositions and methods relating to the use of cationic and monobasic amino acids combined with ketoacids for the purposes of regulating molecular signals to control anabolic and anti-catabolic activity in skeletal muscular development are disclosed. The present invention is designed to influence the genetic control system for muscle protein synthesis to stimulate muscle growth, increase muscle mass, decrease muscle catabolism, decrease recovery time and to treat muscle wasting and/or degeneration. Said compositions are to be administered to a subject one to four times daily.
A dietary supplement and method for increasing energy and mental alertness of an individual, e.g. a human or an animal, is provided comprising at least Caffeine Anhydrous, Taurine, an extract of American Ginseng Root and extract of Green Tea leaf and tender shoots. Additionally, a method for increasing energy and mental alertness in an individual is also provided.
brevets